Next Generation
Genomics and Medicine
18 - 21 May 2010
Next generation sequencing and genotyping coupled with computational advances have allowed the comprehensive and precise investigation of complex biological systems.
Such advances have provided new insights in biology and new understandings of human disease.
The complex and massive datasets require new systems approaches to data analysis and open up the possibility of synthetic reconstructions of biological systems.
The HGM 2010 will explore the interface between these next generation technologies and human biology and pathophysiology. The focus will be on the integration of biology, computational sciences, and genomic technologies towards resolving complex biological and medical questions.
We will discuss the necessary processes such as biobanking that will enable this integration. The impact of this science on ethics and society, and on the aspirations of emerging countries will also be explored.
Genomics and the Bioeconomy
Special Joint HUGO and OECD Conference
17 May 2010
One of the greatest promises of biosciences today is for the harnessing of living processes for human health, for bioenergy, for environmental remediation, and for food production. The basis of this promise is the prospect of unlocking all information in the genomes of living creatures.
This, coupled with the ability to experimentally and computationally decipher the function of all genes and to control their complex interactions on a genome scale place solutions to difficult problems within our grasp.
The breadth and power of these genomic approaches now become tools for value creation that can be spun into economic benefit. The uniqueness of these genomic technologies is that they are modular and can be established with relative facility. Moreover, the value is in the data that can be distributed for analysis.
In this special symposium, HUGO and the OECD are partnering to discuss the impact of genomics on the bioeconomy. Our discussion will be the basis of an analytical paper that will inform policy makers on the unique opportunities in genomics for national development.
